These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study. Xu JJ; Gao Z; Zhang Y; Gao LJ; Chen J; Qiao SB; Gao RL; Yang YJ; Xu B; Yuan JQ Catheter Cardiovasc Interv; 2018 Feb; 91(S1):566-572. PubMed ID: 29359390 [TBL] [Abstract][Full Text] [Related]
7. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome. Paravattil B; Elewa H J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Wimmer NJ; Dufour AB; Cho K; Gagnon DR; Quach L; Ly S; Do JM; Ostrowski S; Michael Gaziano J; Faxon DP; Kinlay S Catheter Cardiovasc Interv; 2017 Jun; 89(7):1176-1184. PubMed ID: 27860195 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765 [TBL] [Abstract][Full Text] [Related]
10. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Costa F; van Klaveren D; James S; Heg D; Räber L; Feres F; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Zanchin T; Palmerini T; Wallentin L; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M; Lancet; 2017 Mar; 389(10073):1025-1034. PubMed ID: 28290994 [TBL] [Abstract][Full Text] [Related]
11. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442 [TBL] [Abstract][Full Text] [Related]
12. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study. Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830 [TBL] [Abstract][Full Text] [Related]
13. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. Yu J; Baber U; Mastoris I; Dangas G; Sartori S; Steg PG; Cohen DJ; Giustino G; Chandrasekhar J; Ariti C; Witzenbichler B; Henry TD; Kini AS; Krucoff MW; Gibson CM; Chieffo A; Moliterno DJ; Colombo A; Pocock S; Mehran R JACC Cardiovasc Interv; 2016 Jul; 9(14):1461-9. PubMed ID: 27478113 [TBL] [Abstract][Full Text] [Related]
14. High platelet reactivity--the challenge of prolonged anticoagulation therapy after ACS. Brouwer MA; Jaspers Focks J; Verheugt FW Thromb Haemost; 2013 May; 109(5):799-807. PubMed ID: 23426079 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy? Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358 [TBL] [Abstract][Full Text] [Related]
16. Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial. Ariotti S; Adamo M; Costa F; Patialiakas A; Briguori C; Thury A; Colangelo S; Campo G; Tebaldi M; Ungi I; Tondi S; Roffi M; Menozzi A; de Cesare N; Garbo R; Meliga E; Testa L; Gabriel HM; Ferlini M; Vranckx P; Valgimigli M; JACC Cardiovasc Interv; 2016 Mar; 9(5):426-36. PubMed ID: 26965932 [TBL] [Abstract][Full Text] [Related]
18. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351 [TBL] [Abstract][Full Text] [Related]
19. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Pandit A; Giri S; Hakim FA; Fortuin FD Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084 [TBL] [Abstract][Full Text] [Related]
20. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial. Camaro C; Damen SA; Brouwer MA; Kedhi E; Lee SW; Verdoia M; Barbieri L; Rognoni A; van T Hof AW; Ligtenberg E; de Boer MJ; Suryapranata H; De Luca G Am Heart J; 2016 Aug; 178():37-44. PubMed ID: 27502850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]